George D. Carystinos, Ph.D.
Affiliations: | 2001 | McGill University, Montreal, QC, Canada |
Area:
Pharmacology, OncologyGoogle:
"George Carystinos"Parents
Sign in to add mentor| Gerald Batist | grad student | 2001 | McGill | |
| (Molecular studies on the therapeutic implications and regulation of connexin 43.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kandouz M, Bier A, Carystinos GD, et al. (2004) Connexin43 pseudogene is expressed in tumor cells and inhibits growth. Oncogene. 23: 4763-70 |
| Carystinos GD, Kandouz M, Alaoui-Jamali MA, et al. (2003) Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence. Molecular Pharmacology. 63: 821-31 |
| Carystinos GD, Bier A, Batist G. (2001) The role of connexin-mediated cell-cell communication in breast cancer metastasis. Journal of Mammary Gland Biology and Neoplasia. 6: 431-40 |
| Carystinos GD, Alaoui-Jamali MA, Phipps J, et al. (2001) Upregulation of gap junctional intercellular communication and connexin 43 expression by cyclic-AMP and all-trans-retinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells Cancer Chemotherapy and Pharmacology. 47: 126-132 |
| Laird DW, Fistouris P, Batist G, et al. (1999) Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Research. 59: 4104-10 |
| Carystinos GD, Katabi MM, Laird DW, et al. (1999) Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy Clinical Cancer Research. 5: 61-68 |
| Chen X, Carystinos GD, Batist G. (1998) Potential for selective modulation of glutathione in cancer chemotherapy. Chemico-Biological Interactions. 111: 263-75 |